ResearcherDalhousie UniversityActive in the last 2 years
Boris Gala-López
Matched on ORCID iD 0000-0003-1179-2085; OpenAlex author ID A5090565037. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 4
- Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/curroncol33020088↗
- Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy. Co-author DOI 10.1016/j.tranon.2025.102362↗
- Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1730817↗
- Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. Co-author DOI 10.3390/curroncol31100461↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ravi Ramjeesingh · 4 shared papers, 2024–2026 · strength 0.93
- Paper Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker … DOI 10.1016/j.tranon.2025.102362↗
- Paper Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol33020088↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Thomas Arnason · 3 shared papers, 2025–2026 · strength 0.77
- Paper Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker … DOI 10.1016/j.tranon.2025.102362↗
- Paper Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol33020088↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Thomas Samson · 3 shared papers, 2025–2026 · strength 0.77
- Paper Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker … DOI 10.1016/j.tranon.2025.102362↗
- Paper Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma. DOI 10.3390/curroncol33020088↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Riley J. Arseneau · 3 shared papers, 2024–2025 · strength 0.67
- Paper Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker … DOI 10.1016/j.tranon.2025.102362↗
- Paper Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. DOI 10.3389/fimmu.2025.1730817↗
- Paper Canadian National Pancreas Conference 2023: A Review of Multidisciplinary Engagement in Pancreatic Cancer Care. DOI 10.3390/curroncol31100461↗
- Carley Bekkers · 2 shared papers, 2025 · strength 0.51
- Jeanette E. Boudreau · 2 shared papers, 2025–2026 · strength 0.50
- Stacey N. Lee · 2 shared papers, 2024–2025 · strength 0.40
- Sharon E. Clarke · 1 shared paper, 2026 · strength 0.26
- Chloe Cyr · 1 shared paper, 2024 · strength 0.16
- Masoom A. Haider · 1 shared paper, 2024 · strength 0.16
- Keith John Roberts · 1 shared paper, 2024 · strength 0.16
- Sharlene Gill · 1 shared paper, 2024 · strength 0.16
- Christina Kim · 1 shared paper, 2024 · strength 0.16
- Jessica L. Nickerson · 1 shared paper, 2024 · strength 0.16
- Sylvia S. W. Ng · 1 shared paper, 2024 · strength 0.16
- Erica S. Tsang · 1 shared paper, 2024 · strength 0.16
- George Zogopoulos · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.